Jump to main content Jump to sidebar

blurb.social: Discover the web

Forums

Log in
Sign up

Overview
Submissions
Comments

globenewswire9432

Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on June 18, 2024 at 9:36 PM in business

No comments

30

Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5 - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on March 15, 2024 at 8:31 PM in business

No comments

25

Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn's & Colitis Congress - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on January 30, 2024 at 1:06 PM in business

No comments

2

Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on January 23, 2024 at 12:02 PM in business

No comments

52

Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on January 5, 2024 at 11:00 AM in business

No comments

63

EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on December 5, 2023 at 12:02 PM in business

No comments

6

BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on November 15, 2023 at 12:16 PM in business

No comments

58

Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023 - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on November 14, 2023 at 1:33 PM in business

No comments

36

United Therapeutics to Acquire Miromatrix Medical - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on October 31, 2023 at 10:05 AM in business

No comments

62

LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on October 25, 2023 at 10:59 AM in business

No comments

5

Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on October 14, 2023 at 3:43 AM in business

No comments

10

Tempest Adopts Limited Duration Stockholder Rights Plan - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on October 12, 2023 at 12:01 PM in business

No comments

19

Akero Therapeutics Reports Encouraging 36-Week Analysis of 96-Week Phase 2b SYMMETRY Study, with a Trend on Fibrosis Improvement and Statistically Significant Results for NASH Resolution, Markers of Liver Injury and Fibrosis, Insulin Sensitization an - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on October 11, 2023 at 11:00 AM in business

No comments

58

Tilray Brands Reports Q1 2024 Financial Results - GlobeNewswire

globenewswire.com

Submitted by globenewswire9432 on October 5, 2023 at 11:00 AM in business

No comments

20

globenewswire9432

Registered on October 3, 2023

We love you.